Clinical Trials Directory

Trials / Sponsors / Romark Laboratories L.C.

Romark Laboratories L.C.

Industry · 29 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnTrial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe I
COVID-19
Phase 32024-08-01
WithdrawnTrial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness
COVID-19
Phase 32024-08-01
TerminatedTrial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus
Enterovirus, Rhinovirus
Phase 32020-08-19
CompletedTrial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
COVID-19
Phase 32020-08-13
CompletedTrial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVI
COVID-19, Viral Respiratory Illnesses
Phase 32020-05-13
TerminatedTrial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and
COVID-19, Viral Respiratory Illnesses
Phase 32020-05-12
CompletedStudy of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B
Chronic Hepatitis B
Phase 22019-10-22
CompletedEfficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Enterovirus, Rhinovirus
Phase 32018-09-11
CompletedA Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazox
Influenza
Phase 32018-01-17
CompletedTrial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Influenza
Phase 32015-12-01
CompletedSafety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Influenza
Phase 32013-03-01
CompletedSafety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Influenza
Phase 2 / Phase 32010-12-01
TerminatedStudy of Nitazoxanide in Adults With Acute Uncomplicated Influenza
Influenza
Phase 22010-01-01
CompletedStudy of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Chronic Hepatitis C
Phase 22008-03-01
CompletedStudy of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Chronic Hepatitis C
Phase 22007-07-01
TerminatedStudy of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease
Clostridium Infections
Phase 32006-12-01
Completed4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepati
Chronic Hepatitis C
Phase 22006-08-01
CompletedStudy of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatiti
Chronic Hepatitis C
Phase 2 / Phase 32006-06-01
CompletedEfficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
Rotavirus Infection, Viral Gastroenteritis Due to Rotavirus
Phase 22005-12-01
CompletedStudy of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of He
Chronic Hepatitis C
Phase 22005-12-01
TerminatedStudy of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
Crohn's Disease
Phase 22005-08-01
CompletedNitazoxanide for the Treatment of Prolonged Diarrhea in Children
Diarrhea
Phase 32005-03-01
CompletedStudy of Nitazoxanide in the Treatment of Chronic Hepatitis C
Chronic Hepatitis C
Phase 22005-02-01
CompletedStudy of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children
Rotavirus Infection, Adenoviridae Infection, Norovirus Infection
Phase 2 / Phase 32005-02-01
CompletedStudy of Nitazoxanide in the Treatment of Amebiasis in Children
Amebiasis
Phase 32004-02-01
CompletedStudy of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
Amebiasis
Phase 32004-02-01
CompletedStudy of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
Clostridium Difficile
Phase 22004-01-01
TerminatedSafety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
Cryptosporidiosis, HIV Infections
Phase 32000-02-01
UnknownA Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
Cryptosporidiosis, HIV Infections
N/A